Brown Lisle Cummings Inc. Has $1.20 Million Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Brown Lisle Cummings Inc. raised its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 30.2% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,424 shares of the medical equipment provider’s stock after acquiring an additional 562 shares during the quarter. Brown Lisle Cummings Inc.’s holdings in Intuitive Surgical were worth $1,201,000 as of its most recent SEC filing.

Other institutional investors have also bought and sold shares of the company. Atala Financial Inc bought a new stake in Intuitive Surgical during the fourth quarter valued at $25,000. Parvin Asset Management LLC bought a new stake in Intuitive Surgical during the fourth quarter valued at $26,000. Global Financial Private Client LLC boosted its position in Intuitive Surgical by 253.3% during the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider’s stock valued at $26,000 after acquiring an additional 38 shares during the last quarter. BankPlus Trust Department bought a new stake in Intuitive Surgical during the fourth quarter valued at $28,000. Finally, Hurley Capital LLC bought a new position in shares of Intuitive Surgical during the 4th quarter worth about $28,000. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Down 0.0%

Intuitive Surgical stock opened at $509.36 on Monday. Intuitive Surgical, Inc. has a 52 week low of $413.82 and a 52 week high of $616.00. The company’s 50 day moving average price is $528.03 and its two-hundred day moving average price is $537.31. The stock has a market cap of $182.56 billion, a P/E ratio of 74.69, a P/E/G ratio of 5.40 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. The firm had revenue of $2.25 billion for the quarter, compared to analysts’ expectations of $2.19 billion. During the same quarter last year, the firm earned $1.50 EPS. On average, equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insiders Place Their Bets

In other news, EVP Gary Loeb sold 1,700 shares of the firm’s stock in a transaction that occurred on Friday, April 25th. The shares were sold at an average price of $513.18, for a total transaction of $872,406.00. Following the completion of the sale, the executive vice president now owns 2,245 shares in the company, valued at $1,152,089.10. This trade represents a 43.09% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, SVP Mark Brosius sold 216 shares of the firm’s stock in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $563.11, for a total transaction of $121,631.76. Following the sale, the senior vice president now owns 907 shares of the company’s stock, valued at approximately $510,740.77. The trade was a 19.23% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 4,998 shares of company stock valued at $2,611,577 in the last 90 days. 0.70% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on ISRG. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Thursday, June 5th. BTIG Research set a $560.00 price target on Intuitive Surgical and gave the stock a “buy” rating in a research note on Monday, April 14th. Citigroup reaffirmed a “buy” rating and set a $650.00 price target (up from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. Truist Financial dropped their price target on Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating on the stock in a research note on Wednesday, April 23rd. Finally, Piper Sandler dropped their price target on Intuitive Surgical from $670.00 to $575.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 23rd. One analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus price target of $588.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.